PATENT CLAIM ANALYSIS

Application Number: 16026901
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "230200"]

Abstract:
The invention features compounds of Formula (I), Formula (I)-A and Formula (I)-B as disclosed herein, as well as methods of synthesis, therapy, diagnostics, and assays.

Claim (Index 18):
A method of treating leukemia and lymphoma, comprising administering to a patient in need thereof a composition comprising the compound of  claim 1 .

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.69565
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15312482', '13062777', '12445141', '14396678', '15696547']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7172652632669355
- 35 USC 102 Novelty (BERT): 0.5787886127254918
- Combined Prediction Score: 0.7034175982127912
- Mean Citation Score: 261.58608
- Max Citation Score: 479.04376
- Similarity Product: 387.57396301961415

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test